Skip to main content
. 2024 Nov 8;12(11):2562. doi: 10.3390/biomedicines12112562

Figure 5.

Figure 5

Bidirectional Mendelian randomization (MR) analyses between META-IBD and 4 immune-mediated diseases (ankylosing spondylitis, psoriasis, iridocyclitis, and psoriatic arthritis). Estimates and 95% confidence intervals (CIs) are shown using square plots and error bars.